drugset / Trial / NCT02793960

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

NCT02793960

Phase 1 Completed 11 enrolled Shasa Hu BPGbio · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a single-center study to investigate the effects of a topical cream on patients 12 years of age and older that have been diagnosed with epidermolysis bullosa.

Timeline

Start
2016-08-10
Primary completion
2019-08-26
Completion
2019-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified 3 % Topical

Indications